ClearPoint Neuro
CLPT
107 hedge funds and large institutions have $223M invested in ClearPoint Neuro in 2025 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 30 increasing their positions, 27 reducing their positions, and 15 closing their positions.
137% more call options, than puts
Call options by funds: $13M | Put options by funds: $5.49M
104% more capital invested
Capital invested by funds: $109M → $223M (+$113M)
73% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 15
11% more funds holding
Funds holding: 96 → 107 (+11)
11% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 27
2.36% more ownership
Funds ownership: 32.72% → 35.08% (+2.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$3.4M |
| 2 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
+$3.34M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$2.49M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.44M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$3.46M |
| 2 |
Goldman Sachs
New York
|
-$2.14M |
| 3 |
Financial Engines Advisors
Santa Clara,
California
|
-$1.71M |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
-$1.41M |
| 5 |
Morgan Stanley
New York
|
-$1.14M |
CLPT Hedge Fund Activity: Q3 2025 in Review
107 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q3 2025, worth a combined $223M — up 104% from $109M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new CLPT positions and 15 closed out — a net gain of 11 holders — while 30 added to existing stakes and 27 trimmed.
The largest buyer was Two Sigma Investments, adding an estimated $3.4M. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $3.46M sold.
- 107 institutional investors held ClearPoint Neuro (CLPT) as of Q3 2025, up from 96 in Q2 2025.
- Funds reported $223M of ClearPoint Neuro stock for Q3 2025, up 104% quarter-over-quarter.
- 26 funds opened new ClearPoint Neuro positions in Q3 2025 and 15 closed out, a net change of +11 holders.
- The largest ClearPoint Neuro buyer in Q3 2025 was Two Sigma Investments, an estimated $3.4M added.
- The largest ClearPoint Neuro seller in Q3 2025 was D.E. Shaw & Co, an estimated $3.46M sold.
Based on aggregated 13F filings for Q3 2025.